RBM26 inhibitors are a class of chemical compounds that specifically target and inhibit the function of RBM26, an RNA-binding protein involved in the regulation of RNA processing, particularly pre-mRNA splicing. RBM26 plays an essential role in coordinating the assembly and function of the spliceosome, a complex molecular machine responsible for removing introns and joining exons in pre-mRNA transcripts. This precise regulation ensures the proper formation of mature mRNA, which is critical for the accurate expression of proteins within cells. Inhibitors of RBM26 work by blocking its ability to bind to RNA or interact with other splicing factors, thereby disrupting its involvement in the splicing process and affecting the production of correctly spliced mRNA transcripts.
Research into RBM26 inhibitors provides insights into how RNA splicing is regulated at the molecular level and the broader implications of disrupting this regulation. By using RBM26 inhibitors, scientists can investigate how changes in RNA splicing influence gene expression patterns, protein production, and cellular function. These inhibitors help clarify the role of RBM26 in maintaining splicing fidelity and its interactions with other components of the spliceosome. Furthermore, the study of RBM26 inhibition sheds light on the dynamic mechanisms of post-transcriptional gene regulation, highlighting how cells control the diversity and stability of their protein output. Through this research, RBM26 inhibitors offer valuable tools for understanding the complex network of RNA-binding proteins and their critical roles in gene expression and cellular adaptation to changing conditions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
Inhibits RNA polymerase II, which could decrease the transcription of RBM26 mRNA. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Binds to DNA and disrupts RNA synthesis, potentially lowering RBM26 mRNA levels. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Acts broadly to suppress transcription, possibly leading to decreased RBM26 expression. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
Inhibits transcription elongation by RNA polymerase II, which could reduce RBM26 mRNA production. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $311.00 | ||
Cyclin-dependent kinase inhibitor that could negatively affect RBM26 transcription. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Binds to GC-rich DNA, possibly interfering with RBM26 gene transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor potentially altering RBM26 gene expression via epigenetic changes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Histone deacetylase inhibitor that could affect chromatin structure and RBM26 expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Interferes with nucleic acid replication and transcription, which may influence RBM26 mRNA levels. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor, potentially affecting RBM26 expression indirectly by altering protein degradation. | ||||||